This study is enrolling participants by invitation only. This is a multicenter, open-label, long-term extension study of the safety and efficacy of ADP101 for oral immunotherapy in food allergic children and adults who completed the Harmony study (protocol ADP101-MA-01).
This is an open-label, safety extension study for participants who participated in the Harmony study (protocol ADP101-MA-01).